Cite

HARVARD Citation

    Roeper, J. et al. (n.d.). 1447PRisk of not receiving second-line therapy is high in EGFR mt+ pts: Real world data of certified lung cancer centers on treatment sequence in EGFR mt+ pts. Annals of oncology. p. . [Online]. 
  
Back to record